RT Journal Article SR Electronic T1 The causal correlation between gastroesophageal reflux disease and chronic widespread pain: a bidirectional mendelian randomization study JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.05.06.24306927 DO 10.1101/2024.05.06.24306927 A1 Chen, Menglin A1 Tu, Houshu A1 Zhou, Jiaoli A1 Zhang, Yi A1 Wen, Shuting A1 Xiao, Yao A1 He, Ling YR 2024 UL http://medrxiv.org/content/early/2024/05/06/2024.05.06.24306927.abstract AB Background Previous observational research found a relationship between gastroesophageal reflux disease (GERD) and chronic widespread pain (CWP). Despite this, it is unknown which, if any, of the conditions produces the other. Our study will use bidirectional Mendelian randomization (MR) to evaluate their causal link.Methods We examined two sets of publically accessible data from genome-wide association studies (GWAS): GERD (129,080 cases and 602,604 controls) and CWP (6,914 cases and 242,929 controls). We used the inverse variance weighting (IVW) approach as the major analysis method, but we also ran weighted median and MR-Egger regression analyses. We performed various sensitivity studies to assess the conclusions’ consistency, horizontal pleiotropy, and stability.Results MR analysis showed that CWP increased the risk of developing GERD [NSNP = 4, odds ratio (OR): 245.244; 95% confidence interval (CI): 4.35E+00,1.38E+04; p = 0.007 < 0.05] and vice versa (NSNP = 28; OR:1.019; 95% CI: 1.009-1.029; p = 0.029 < 0.05). Bidirectional evidence of causality existed. The sensitivity analysis demonstrated the robustness and reliability of the findings.Conclusions Our study demonstrated a bidirectional causal relationship between GERD and chronic widespread pain, and future interventions for CWP may be an effective strategy for preventing or mitigating GERD and vice versa.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:It is important to emphasize that there was no sample duplication between the two research groups and that every participant was of European heritage, reducing the possibility of ethnic bias.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesIf the data are all contained within the manuscript and/or Supporting Information files. http://www.phenoscanner.medschl.cam.ac.uk